Khiron Life Sciences – a Toronto-based company with its main operations in Colombia – announced Thursday that it completed the first export from Colombia of high-THC medical cannabis products.
The first finished, registered cannabis medicine became available to patients in Peruvian pharmacies this week, Marijuana Business Daily has learned.
A new medical cannabis product is available in Peru, another sign the market is moving in the right direction in terms of business opportunities.
New product registration underscores the limited but increasing Latin American intraregional medical cannabis trade, independent from North American cannabis production.
Brazil is poised to become the largest Latin American cannabis market in the long term, but regulators have been slow to expand the existing program over the last few years.
Opportunities are also slow to develop in Paraguay and Peru, where medical cannabis laws were passed recently but still lack details about implementation.
